Stock Research for RDY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

RDY Stock Chart & Research Data

The RDY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RDY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


RDY Due diligence Resources & Stock Charts

The RDY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View RDY Detailed Price Forecast - CNN Money CNN View RDY Detailed Summary - Google Finance
Yahoo View RDY Detailed Summary - Yahoo! Finance Zacks View RDY Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View RDY Trends & Analysis - Trade-Ideas Barrons View RDY Major Holders - Barrons
NASDAQ View RDY Call Transcripts - NASDAQ Seeking View RDY Breaking News & Analysis - Seeking Alpha
Spotlight View RDY Annual Report - CompanySpotlight.com OTC Report View RDY OTC Short Report - OTCShortReport.com
TradeKing View RDY Fundamentals - TradeKing Charts View RDY SEC Filings - Bar Chart
WSJ View Historical Prices for RDY - The WSJ Morningstar View Performance/Total Return for RDY - Morningstar
MarketWatch View the Analyst Estimates for RDY - MarketWatch CNBC View the Earnings History for RDY - CNBC
StockMarketWatch View the RDY Earnings - StockMarketWatch MacroAxis View RDY Buy or Sell Recommendations - MacroAxis
Bullish View the RDY Bullish Patterns - American Bulls Short Pains View RDY Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View RDY Stock Mentions - StockTwits PennyStocks View RDY Stock Mentions - PennyStockTweets
Twitter View RDY Stock Mentions - Twitter Invest Hub View RDY Investment Forum News - Investor Hub
Yahoo View RDY Stock Mentions - Yahoo! Message Board Seeking Alpha View RDY Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for RDY - SECform4.com Insider Cow View Insider Transactions for RDY - Insider Cow
CNBC View RDY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for RDY - OTC Markets
Yahoo View Insider Transactions for RDY - Yahoo! Finance NASDAQ View Institutional Holdings for RDY - NASDAQ


Stock Charts

FinViz View RDY Stock Insight & Charts - FinViz.com StockCharts View RDY Investment Charts - StockCharts.com
BarChart View RDY Stock Overview & Charts - BarChart Trading View View RDY User Generated Charts - Trading View


Latest Financial News for RDY

Spotlight On Dr Reddy’s Laboratories Limited’s (NSE:DRREDDY) Fundamentals
Posted on Thursday June 21, 2018

Dr Reddy’s Laboratories Limited (NSE:DRREDDY) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. InRead More...


Dr. Reddy's Laboratories Announces the Launch of Levetiracetam in Sodium Chloride Injection in the U.S. Market
Posted on Tuesday June 19, 2018

Dr. Reddy’s Laboratories Ltd. announced today that it has launched Levetiracetam in Sodium Chloride Injection, 500 mg/100 mL , 1,000 mg/100 mL , and 1,500 mg/100 mL single-dose infusion bags, a therapeutic equivalent generic version of HQ Specialty Pharma Corporation’s Levetiracetam in Sodium Chloride Injection, approved by the U.S.


Company News For Jun 18, 2018
Posted on Monday June 18, 2018

Companies In The News are: GOOS,FB,RDY,FOXA


Dr. Reddy's Laboratories defends its right to launch Buprenorphine and Naloxone Sublingual Film in the U.S. Market
Posted on Friday June 15, 2018

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that following the launch of its generic Buprenorphine and Naloxone Sublingual Film in the U.S. Market, the U.S. District Court for the District of New Jersey has received and reviewed an emergency application from the plaintiffs in the current patent litigation for a temporary restraining order and preliminary injunction against Dr. Reddy’s. Pending a hearing and decision on the injunction application, the court has issued a temporary restraining order against Dr. Reddy’s with respect to further sales and commercialization of Buprenorphine and Naloxone Sublingual Film within the U.S. The court order does not include a prohibition on commercial manufacturing of the product.


Enter a stock symbol to view the stock details.